Literature DB >> 23716993

Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.

Xiao-Ping Niu1, Bao-Ping Yu, Yun-Dong Wang, Zhen Han, Shao-Fen Liu, Chi-Yi He, Guo-Zheng Zhang, Wan-Chun Wu.   

Abstract

AIM: To analyze risk factors for refractoriness to proton pump inhibitors (PPIs) in patients with non-erosive reflux disease (NERD).
METHODS: A total of 256 NERD patients treated with the PPI esomeprazole were enrolled. They were classified into symptom-free and residual symptoms groups according to Quality of Life in Reflux and Dyspepsia (QolRad) scale. All subjects completed questionnaires on psychological status (self-rating anxiety scale; self-rating depression scale) and quality of life scale (Short Form 36). Multivariate analysis was used to determine the predictive factors for PPI responses.
RESULTS: According to QolRad, 97 patients were confirmed to have residual reflux symptoms, and the remaining 159 patients were considered symptom free. There were no significant differences between the two groups in lifestyle factors (smoking and alcohol consumption), age, Helicobacter pylori infection, and hiatal hernia. There were significant differences between the two groups in relation to sex, psychological distress including anxiety and depression, body mass index (BMI), and irritable bowel syndrome (IBS) (P < 0.05). Logistic regression analysis found that BMI < 23, comorbid IBS, anxiety, and depression were major risk factors for PPI resistance. Symptomatic patients had a lower quality of life compared with symptom-free patients.
CONCLUSION: Some NERD patients are refractory to PPIs and have lower quality of life. Residual symptoms are associated with psychological distress, intestinal disorders, and low BMI.

Entities:  

Keywords:  Non-erosive reflux disease; Proton pump inhibitors; Refractoriness; Risk factors

Mesh:

Substances:

Year:  2013        PMID: 23716993      PMCID: PMC3662953          DOI: 10.3748/wjg.v19.i20.3124

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  J E Ware; M Kosinski; B Gandek; N K Aaronson; G Apolone; P Bech; J Brazier; M Bullinger; S Kaasa; A Leplège; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

2.  Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.

Authors:  Sui Peng; Li-shou Xiong; Ying-lian Xiao; An-jiang Wang; Jin-kun Lin; Pin-jin Hu; Min-hu Chen
Journal:  Chin Med J (Engl)       Date:  2010-08-05       Impact factor: 2.628

3.  Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.

Authors:  Edoardo Savarino; Radu Tutuian; Patrizia Zentilin; Pietro Dulbecco; Daniel Pohl; Elisa Marabotto; Andrea Parodi; Giorgio Sammito; Lorenzo Gemignani; Giorgia Bodini; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

4.  Anxiety and depression in various functional gastrointestinal disorders: do differences exist?

Authors:  Juanda Leo Hartono; Sanjiv Mahadeva; Khean-Lee Goh
Journal:  J Dig Dis       Date:  2012-05       Impact factor: 2.325

5.  Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!

Authors:  Carmelo Scarpignato
Journal:  Neurogastroenterol Motil       Date:  2012-08       Impact factor: 3.598

6.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

7.  Psychological factors, quality of life, and gastrointestinal symptoms in patients with erosive and non-erosive reflux disorder.

Authors:  Zoltán Kovács; Olga Kerékgyártó
Journal:  Int J Psychiatry Med       Date:  2007       Impact factor: 1.210

8.  A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese population.

Authors:  W M Wong; K F Lam; K C Lai; W M Hui; W H C Hu; C L K Lam; N Y H Wong; H H X Xia; J Q Huang; A O O Chan; S K Lam; B C Y Wong
Journal:  Aliment Pharmacol Ther       Date:  2003-06-01       Impact factor: 8.171

9.  Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.

Authors:  E S Lee; N Kim; S H Lee; Y S Park; J W Kim; S H Jeong; D H Lee; H C Jung; I S Song
Journal:  Aliment Pharmacol Ther       Date:  2009-04-15       Impact factor: 8.171

10.  Prevalence of, and factors associated with, gastroesophageal reflux disease: a population-based study in Shanghai, China.

Authors:  X-Q Ma; Y Cao; R Wang; X Yan; Y Zhao; D Zou; M-A Wallander; S Johansson; W Liu; Z Gu; J Zhao; J He
Journal:  Dis Esophagus       Date:  2008-12-22       Impact factor: 3.429

View more
  7 in total

1.  Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.

Authors:  Nobuyuki Matsuhashi; Mineo Kudo; Norimasa Yoshida; Kazunari Murakami; Mototsugu Kato; Tsuyoshi Sanuki; Atsushi Oshio; Takashi Joh; Kazuhide Higuchi; Ken Haruma; Koji Nakada
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

2.  Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life.

Authors:  Xiao-Jun Yang; Hong-Mei Jiang; Xiao-Hua Hou; Jun Song
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

3.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

Review 4.  Efficacy of Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-Analysis.

Authors:  Eun Jeong Gong; Chan Hyuk Park; Da Hyun Jung; Sun Hyung Kang; Ju Yup Lee; Hyun Lim; Do Hoon Kim
Journal:  J Pers Med       Date:  2022-04-12

Review 5.  Sex and Gender Differences in Gastroesophageal Reflux Disease.

Authors:  Young Sun Kim; Nayoung Kim; Gwang Ha Kim
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

6.  Analysis of Psychological and Gut Microbiome Characteristics in Patients With Non-erosive Reflux Disease.

Authors:  Fan Yang; Xin-Hui Xie; Xi Li; Hui-Na Liao; Bing Zou
Journal:  Front Psychiatry       Date:  2022-01-13       Impact factor: 4.157

Review 7.  Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors.

Authors:  Salvatore Tolone; Giorgia Gualtieri; Edoardo Savarino; Marzio Frazzoni; Nicola de Bortoli; Manuele Furnari; Giuseppina Casalino; Simona Parisi; Vincenzo Savarino; Ludovico Docimo
Journal:  World J Gastrointest Surg       Date:  2016-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.